Last reviewed · How we verify
NCT02649881: OCT pathology
Diagnosis of Macrophage Coronary Plaque by Optical Tomographic Imaging
trial testing The heart subject will undergo OCT in Atherosclerotic Plaque in 20 participants. Completed in 31 August 2017.
31 August 2017
Quick facts
| Lead sponsor | Young-Hak Kim, MD, PhD |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 12 May 2015 |
| Primary completion | 31 August 2017 |
| Estimated completion | 31 August 2017 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- The heart subject will undergo OCT
Conditions studied
- Atherosclerotic Plaque — all drugs for Atherosclerotic Plaque →
Sponsor
Young-Hak Kim, MD, PhD
Who can join
18 and older, any sex, with Atherosclerotic Plaque. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluated optimal macrophage diagnosis algorithm through comparative analysis between coronary artery, OCT image, and IVUS, and improve a diagnosis rate of vulnerable coronary plaque accompanied with macrophage infiltration.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02649881
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atherosclerotic Plaque
Currently open trials in the same condition.
- NCT06424860 — Fish Oil, Metformin and Heart Health in PCOS · Phase 1 · recruiting
- NCT06902740 — PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis · Phase 4 · recruiting
- NCT06603363 — Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT · NA · recruiting
- NCT05438121 — STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB) · recruiting
Other Young-Hak Kim, MD, PhD trials
Trials by the same sponsor.
- NCT02814578 — Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbabl · NA · terminated
- NCT02175186 — Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coro · Phase 4 · completed
- NCT02208388 — Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial · NA · recruiting
- NCT01696006 — Perfusion CT Registry · completed
- NCT02121054 — Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Art · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02649881 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Young-Hak Kim, MD, PhD
- Last refreshed: 6 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02649881.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing